Akoya announced the launch of PhenoCode™ Signature Panels for high-throughput spatial biomarker discovery and validation on the PhenoImager® platforms, providing the flexibility to keep pace with the dynamic combination therapy landscape. Additionally, Akoya has brought new datasets of spatial imaging of complementary RNA and protein biomarkers on the PhenoCycler®-Fusion system, which reveal insights into tumor biology and immunotherapyresponse..https://www.gaiascience.com.sg/branddetails/akoya-biosciences
Identification of Rare and Novel Alleles in FFPE Tumor Samples | ESHG 2015 Po...Thermo Fisher Scientific
Tumors are becoming recognized as genetically heterogeneous masses of cells with different clonal histories. Identifying the mutations present in these heterogeneous masses can lead to important insights into the future behavior of the tumor and possible intervention mechanisms. However, the rarity of pathogenic mutations in small subsets of cells can make identification of such alleles difficult. In this study, we demonstrate a complete workflow that facilitates the identification of rare and novel alleles from FFPE tumor sections. We collected small regions with different cellular morphologies from lung tumor samples using laser capture microdissection, extracted both DNA and RNA from these regions, and characterized mutations present and transcript abundances by using Ion AmpliSeq™ targeted sequencing. We show that LCM facilitates the detection of alleles that are not detectable in macrodissected tissue scrapes. We also show that different regions of a tumor have very different patterns of alleles detectable and have a great deal of genetic diversity. Finally, we show that RNA expression patterns are also clearly different in the different regions. Interestingly, dissected regions with similar gross tissue morphologies display differences in alleles present and RNA expression patterns. These results suggest how we may in the future use this method to analyze mutations present in a tumor is to microdissect different subregions of the tumor, and using Ion AmpliSeq™ panels to identify the alleles present in those subregions.
Tumor Mutational Load assessment of FFPE samples using an NGS based assayThermo Fisher Scientific
Understanding the molecular determinants of response to immune checkpoint blockade inhibitors is a critical unmet need for translational oncology research. Research tools to characterize the mutational landscape of cancers may potentially help identify predictive biomarkers for immuno-therapy that can be tested in future studies. Herein, we describe a targeted Ion AmpliSeq assay to determine the mutational load and signature of cancer research samples.
Identification of Rare and Novel Alleles in FFPE Tumor Samples | ESHG 2015 Po...Thermo Fisher Scientific
Tumors are becoming recognized as genetically heterogeneous masses of cells with different clonal histories. Identifying the mutations present in these heterogeneous masses can lead to important insights into the future behavior of the tumor and possible intervention mechanisms. However, the rarity of pathogenic mutations in small subsets of cells can make identification of such alleles difficult. In this study, we demonstrate a complete workflow that facilitates the identification of rare and novel alleles from FFPE tumor sections. We collected small regions with different cellular morphologies from lung tumor samples using laser capture microdissection, extracted both DNA and RNA from these regions, and characterized mutations present and transcript abundances by using Ion AmpliSeq™ targeted sequencing. We show that LCM facilitates the detection of alleles that are not detectable in macrodissected tissue scrapes. We also show that different regions of a tumor have very different patterns of alleles detectable and have a great deal of genetic diversity. Finally, we show that RNA expression patterns are also clearly different in the different regions. Interestingly, dissected regions with similar gross tissue morphologies display differences in alleles present and RNA expression patterns. These results suggest how we may in the future use this method to analyze mutations present in a tumor is to microdissect different subregions of the tumor, and using Ion AmpliSeq™ panels to identify the alleles present in those subregions.
Tumor Mutational Load assessment of FFPE samples using an NGS based assayThermo Fisher Scientific
Understanding the molecular determinants of response to immune checkpoint blockade inhibitors is a critical unmet need for translational oncology research. Research tools to characterize the mutational landscape of cancers may potentially help identify predictive biomarkers for immuno-therapy that can be tested in future studies. Herein, we describe a targeted Ion AmpliSeq assay to determine the mutational load and signature of cancer research samples.
Introduction
Transcriptome analysis
Goal of functional genomics
Why we need functional genomics
Technique
1. At DNA level
2.At RNA level
3. At protein level
4. loss of function
5. functional genomic and bioinformatics
Application
Latest research and reviews
Websites of functional genomics
Conclusions
Reference
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...Thermo Fisher Scientific
In recent years, advances in next-generation sequencing (NGS) technologies have enabled faster and cheaper methods for uncovering the genetic basis of disease. For cancer, NGS based screening for known tumour subtypes can inform diagnosis and allow the clinician to tailor a specific therapy based on testing outcome. Here we present the validation of one such NGS based kit approved for CE-IVD* use to screen for specific chromosomal translocations in non-small cell lung cancer (NSCLC) samples by targeting specific breakpoints in known fusion transcripts.
The kit tested (Oncomine™ Solid Tumour Fusion Transcript Kit) included a single primer poolcontaining amplicon designs to simultaneously screen for over 75 specific rearrangements involving the receptor tyrosine kinase (RTK) genes ALK, RET and ROS1 as well as NTRK1. The panel was compatible with formalin-fixed paraffin-embedded (FFPE) lung tumour samples and achieved high sensitivity down to 10 ng of RNA input. In addition, amplicon assays designed at the 5’ and 3’ ends the RTK genes provide non-specific evidence that a translocation exists in a sample by comparing expression imbalance between the two ends. Validation testing was carried out at three external clinical laboratories (CLIA, CAP, INAB). In addition to positive and negative control samples, each site contributed FFPE lung tumour samples for which ALK fusion status was known prior to NGS library preparation carried out using the Ion AmpliSeq workflow. For site-specific samples (n=144, 16 samples per sequencing run), high concordance, sensitivity and specificity were measured at 97.2%, 90.5% and 98.4%, respectively.
Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...jake9606
Poster Presentation which focuses on the background, production and direction of novel Nanobody Technology as a potential biotherapeutic. Technology has been developed by Ablynx (Belgium) and has many benefits particularly in production compared to Antibodies.
RT-PCR and DNA microarray measurement of mRNA cell proliferationIJAEMSJORNAL
For mRNA quantification, RT-PCR and DNA microarrays have been compared in few studies
(RT-PCR). Healing callus of adult and juvenile rats after femur injury was found to be rich in mRNA at
various stages of the healing process. We used both methods to examine ten samples and a total of 26 genes.
Internal DNA probes tagged with 32P were employed in reverse transcription-polymerase chain reaction
(RT-PCR) to identify genes (RT-PCR). Ten Affymetrix® Rat U34A cRNA microarrays were hybridized with
biotin-labeled cRNA generated from mRNA. There was a wide range of correlation coefficients (r) between
RT-PCR and microarray data for each gene. Meaning became genetically unique because of this diversity.
Relatively lowly expressed genes had the highest r values. The distance between PCR primers and
microarray probes was found to be higher than previously assumed, leading to a drop in agreement between
microarray calls and PCR outcomes. Microarray research showed that RT-PCR expression levels for two
genes had a "floor effect." As a result, PCR primers and microarray probes that overlap in mRNA expression
levels can provide good agreement between these two techniques.
The Karolinska Institute (KI) is the largest centre for medical education and research in Sweden and the home of the Nobel Prize in Physiology or Medicine.
KI consists of 22 departments and 600 research groups dedicated to improving human health through research and higher education.
The role of the Kohonen/Grafström team has been to guide the application, analysis, interpretation and storage of so called “omics” technology-derived data within the service-oriented subproject “ToxBank”.
Forecasting clinical behavior and therapeutic response of human cancer currently utilizes a limited number of tumor markers in combination with characteristics of the patient and their disease. Although few tumor markers and molecular targets exist for evaluation, the wealth of information derived from recent sequencing advancements provides greater opportunities to develop more precise tests for diagnostics, prognostics, therapy selection and monitoring in the future. The objectives of this study are to study miRNA and mRNA expression profiles of laser capture microdissection (LCM)-procured tumor cells and intact serial sections of breast tissue samples using next generation sequencing (NGS) methods. Our hypothesis is that miRNA signatures discerned from specific tumor cell populations more precisely correlate with behavior than that provided by conventional biomarkers from intact tissue samples. Additionally, we hypothesize the data generated in this study will present mRNA signatures informative for breast tumor research and support our miRNA findings through suggesting relevant miRNA:mRNA target associations.
De-identified frozen research samples of primary invasive ductal tumors of known grade and biomarker status containing 35-70% tumor were selected from an IRB-approved Biorepository. Comparison of expressed miRNAs from intact tissue sections with those of cognate tumor cells procured by LCM revealed, in general, that smaller defined miRNA gene sets were expressed in LCM isolated populations of tumor cells. In addition to miRNA sequencing, targeted RNA sequencing with the Ion AmpliSeq™ Transcriptome Human Gene Expression Kit was used to capture mRNA expression information. Data presented here demonstrates high mapping rates for targeted mRNA (>91% of reads) and miRNA (> 88% of reads) libraries. We also demonstrate high technical reproducibility between multiple libraries from the same tumor sample for both mRNA (R>0.99) and miRNA (R>0.97) libraries. We also report suggested miRNA:mRNA target associations identified in our set of breast tumor research samples. These data provide insights into breast cancer biology that may lead to new molecular diagnostics and targets for drug design in the future as well as an improved understanding of the molecular basis of clinical behavior and potential therapeutic response.
PROKARYOTIC TRANSCRIPTOMICS AND METAGENOMICSLubna MRL
After billions of years of evolution, prokaryotes have developed a huge diversity of regulatory mechanisms, many of which are probably uncharacterized. Now that the powerful tool of whole-transcriptome analysis can be used to study the RNA of bacteria and archaea, a new set of un expected RNA-based regulatory strategies might be revealed.
Metagenomics, together with in vitro evolution and high-throughput screening technologies, provides industry with an unprecedented chance to bring biomolecules into industrial application.
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...Thermo Fisher Scientific
Thousands of genes are expressed in a controlled fashion in each eukaryotic cell
determining what a cell can do and dictate normal tissue function. The measurement of
the entire gene expression pattern of a given sample is critical in understanding the
natural homeostatic state of a healthy tissue, as well as providing useful information
when a system is altered due to environmental queues or potentially disease state.
Many technologies have been utilized to measure the entire gene expression profile of a
RNA test sample. DNA microarrays have become a key method to acquire a
comparative snapshot of the gene expression profile from test samples in a high
throughput manner. Quantitative PCR and newer sequencing techniques are popular
alternatives offering highly accurate gene expression measurements, but with limitations
due to cost and complex analysis needs.
To address the challenges of current sequencing based methods of global gene
expression profiling and take advantage of the simplicity of analysis that comes with
defined expression profiling content from technologies such as microarrays, we have
tested the Ion AmpliSeq™ Transcriptome Human Gene Expression Kit using RNA
isolated from invasive ductal tumor samples. This novel approach allows profiling the
global mRNA expression of human RNA in a highly multiplexed fashion using the Ion
Torrent sequencing platform. The results show detection of more genes than popular
microarray platforms with comparable differential gene expression measurements to
quantitative PCR (r = 0.96) and RNA-Seq methods (r = 0.94).
Data presented here demonstrates high on target mapping (>91% of reads) for all
human breast carcinoma libraries. Gene expression values correlated with R>0.99 for
all technical replicates. We saw >64% of the over 22,800 genes in the single pool panel
detected for all libraries. The most highly expressed genes include genes expected to
be over-expressed in breast tumor samples. The Ion AmpliSeq™ Transcriptome Human
Gene Expression Kit is a novel method to measure global gene expression profiles from
human RNA samples in a timely, cost effective, and high throughput manner resulting in
sensitive and accurate gene expression measurements.
Particle Swarm Optimization for Gene cluster IdentificationEditor IJCATR
The understanding of gene regulation is the most basic need for the classification of genes within a DNA. These genes
within the DNA are grouped together into clusters also known as Transcription Units. The genes are grouped into transcription units
for the purpose of construction and regulation of gene expression and synthesis of proteins. This knowledge further contributes as
essential information for the process of drug design and to determine the protein functions of newly sequenced genomes. It is possible
to use the diverse biological information across multiple genomes as an input to the classification problem. The purpose of this work is
to show that Particle Swarm Optimization may provide for more efficient classification as compared to other algorithms. To validate
the approach E.Coli complete genome is taken as the benchmark genome.
The EVOM Auto automates measurements of TEER in epithelial or endothelial monolayers cultured on high throughput screening (HTS) 24 and 96-well and plates utilizing our innovative EVOM technology, qualitatively measuring cell monolayer health and quantitatively measuring cell confluence by determining an increase or a plateau in tissue resistance..https://www.gaiascience.com.sg/productdetails/-evom-auto--high-throughput-screening-system-
ELK Biotech offers thousands of enzyme-linked immunosorbent assay (ELISA) kits for researchers, The species include human, mouse, rat, rabbit, monkey, porcine, etc. As a professional ELISA kits manufacturer and supplier, our ELISA test kits have been strictly quality-controlled to ensure the accuracy of results. Elabscience is committed to providing high quality ELISA kits with a very economical price..https://www.gaiascience.com.sg/productdetails/elisa-kit
Introduction
Transcriptome analysis
Goal of functional genomics
Why we need functional genomics
Technique
1. At DNA level
2.At RNA level
3. At protein level
4. loss of function
5. functional genomic and bioinformatics
Application
Latest research and reviews
Websites of functional genomics
Conclusions
Reference
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...Thermo Fisher Scientific
In recent years, advances in next-generation sequencing (NGS) technologies have enabled faster and cheaper methods for uncovering the genetic basis of disease. For cancer, NGS based screening for known tumour subtypes can inform diagnosis and allow the clinician to tailor a specific therapy based on testing outcome. Here we present the validation of one such NGS based kit approved for CE-IVD* use to screen for specific chromosomal translocations in non-small cell lung cancer (NSCLC) samples by targeting specific breakpoints in known fusion transcripts.
The kit tested (Oncomine™ Solid Tumour Fusion Transcript Kit) included a single primer poolcontaining amplicon designs to simultaneously screen for over 75 specific rearrangements involving the receptor tyrosine kinase (RTK) genes ALK, RET and ROS1 as well as NTRK1. The panel was compatible with formalin-fixed paraffin-embedded (FFPE) lung tumour samples and achieved high sensitivity down to 10 ng of RNA input. In addition, amplicon assays designed at the 5’ and 3’ ends the RTK genes provide non-specific evidence that a translocation exists in a sample by comparing expression imbalance between the two ends. Validation testing was carried out at three external clinical laboratories (CLIA, CAP, INAB). In addition to positive and negative control samples, each site contributed FFPE lung tumour samples for which ALK fusion status was known prior to NGS library preparation carried out using the Ion AmpliSeq workflow. For site-specific samples (n=144, 16 samples per sequencing run), high concordance, sensitivity and specificity were measured at 97.2%, 90.5% and 98.4%, respectively.
Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...jake9606
Poster Presentation which focuses on the background, production and direction of novel Nanobody Technology as a potential biotherapeutic. Technology has been developed by Ablynx (Belgium) and has many benefits particularly in production compared to Antibodies.
RT-PCR and DNA microarray measurement of mRNA cell proliferationIJAEMSJORNAL
For mRNA quantification, RT-PCR and DNA microarrays have been compared in few studies
(RT-PCR). Healing callus of adult and juvenile rats after femur injury was found to be rich in mRNA at
various stages of the healing process. We used both methods to examine ten samples and a total of 26 genes.
Internal DNA probes tagged with 32P were employed in reverse transcription-polymerase chain reaction
(RT-PCR) to identify genes (RT-PCR). Ten Affymetrix® Rat U34A cRNA microarrays were hybridized with
biotin-labeled cRNA generated from mRNA. There was a wide range of correlation coefficients (r) between
RT-PCR and microarray data for each gene. Meaning became genetically unique because of this diversity.
Relatively lowly expressed genes had the highest r values. The distance between PCR primers and
microarray probes was found to be higher than previously assumed, leading to a drop in agreement between
microarray calls and PCR outcomes. Microarray research showed that RT-PCR expression levels for two
genes had a "floor effect." As a result, PCR primers and microarray probes that overlap in mRNA expression
levels can provide good agreement between these two techniques.
The Karolinska Institute (KI) is the largest centre for medical education and research in Sweden and the home of the Nobel Prize in Physiology or Medicine.
KI consists of 22 departments and 600 research groups dedicated to improving human health through research and higher education.
The role of the Kohonen/Grafström team has been to guide the application, analysis, interpretation and storage of so called “omics” technology-derived data within the service-oriented subproject “ToxBank”.
Forecasting clinical behavior and therapeutic response of human cancer currently utilizes a limited number of tumor markers in combination with characteristics of the patient and their disease. Although few tumor markers and molecular targets exist for evaluation, the wealth of information derived from recent sequencing advancements provides greater opportunities to develop more precise tests for diagnostics, prognostics, therapy selection and monitoring in the future. The objectives of this study are to study miRNA and mRNA expression profiles of laser capture microdissection (LCM)-procured tumor cells and intact serial sections of breast tissue samples using next generation sequencing (NGS) methods. Our hypothesis is that miRNA signatures discerned from specific tumor cell populations more precisely correlate with behavior than that provided by conventional biomarkers from intact tissue samples. Additionally, we hypothesize the data generated in this study will present mRNA signatures informative for breast tumor research and support our miRNA findings through suggesting relevant miRNA:mRNA target associations.
De-identified frozen research samples of primary invasive ductal tumors of known grade and biomarker status containing 35-70% tumor were selected from an IRB-approved Biorepository. Comparison of expressed miRNAs from intact tissue sections with those of cognate tumor cells procured by LCM revealed, in general, that smaller defined miRNA gene sets were expressed in LCM isolated populations of tumor cells. In addition to miRNA sequencing, targeted RNA sequencing with the Ion AmpliSeq™ Transcriptome Human Gene Expression Kit was used to capture mRNA expression information. Data presented here demonstrates high mapping rates for targeted mRNA (>91% of reads) and miRNA (> 88% of reads) libraries. We also demonstrate high technical reproducibility between multiple libraries from the same tumor sample for both mRNA (R>0.99) and miRNA (R>0.97) libraries. We also report suggested miRNA:mRNA target associations identified in our set of breast tumor research samples. These data provide insights into breast cancer biology that may lead to new molecular diagnostics and targets for drug design in the future as well as an improved understanding of the molecular basis of clinical behavior and potential therapeutic response.
PROKARYOTIC TRANSCRIPTOMICS AND METAGENOMICSLubna MRL
After billions of years of evolution, prokaryotes have developed a huge diversity of regulatory mechanisms, many of which are probably uncharacterized. Now that the powerful tool of whole-transcriptome analysis can be used to study the RNA of bacteria and archaea, a new set of un expected RNA-based regulatory strategies might be revealed.
Metagenomics, together with in vitro evolution and high-throughput screening technologies, provides industry with an unprecedented chance to bring biomolecules into industrial application.
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...Thermo Fisher Scientific
Thousands of genes are expressed in a controlled fashion in each eukaryotic cell
determining what a cell can do and dictate normal tissue function. The measurement of
the entire gene expression pattern of a given sample is critical in understanding the
natural homeostatic state of a healthy tissue, as well as providing useful information
when a system is altered due to environmental queues or potentially disease state.
Many technologies have been utilized to measure the entire gene expression profile of a
RNA test sample. DNA microarrays have become a key method to acquire a
comparative snapshot of the gene expression profile from test samples in a high
throughput manner. Quantitative PCR and newer sequencing techniques are popular
alternatives offering highly accurate gene expression measurements, but with limitations
due to cost and complex analysis needs.
To address the challenges of current sequencing based methods of global gene
expression profiling and take advantage of the simplicity of analysis that comes with
defined expression profiling content from technologies such as microarrays, we have
tested the Ion AmpliSeq™ Transcriptome Human Gene Expression Kit using RNA
isolated from invasive ductal tumor samples. This novel approach allows profiling the
global mRNA expression of human RNA in a highly multiplexed fashion using the Ion
Torrent sequencing platform. The results show detection of more genes than popular
microarray platforms with comparable differential gene expression measurements to
quantitative PCR (r = 0.96) and RNA-Seq methods (r = 0.94).
Data presented here demonstrates high on target mapping (>91% of reads) for all
human breast carcinoma libraries. Gene expression values correlated with R>0.99 for
all technical replicates. We saw >64% of the over 22,800 genes in the single pool panel
detected for all libraries. The most highly expressed genes include genes expected to
be over-expressed in breast tumor samples. The Ion AmpliSeq™ Transcriptome Human
Gene Expression Kit is a novel method to measure global gene expression profiles from
human RNA samples in a timely, cost effective, and high throughput manner resulting in
sensitive and accurate gene expression measurements.
Particle Swarm Optimization for Gene cluster IdentificationEditor IJCATR
The understanding of gene regulation is the most basic need for the classification of genes within a DNA. These genes
within the DNA are grouped together into clusters also known as Transcription Units. The genes are grouped into transcription units
for the purpose of construction and regulation of gene expression and synthesis of proteins. This knowledge further contributes as
essential information for the process of drug design and to determine the protein functions of newly sequenced genomes. It is possible
to use the diverse biological information across multiple genomes as an input to the classification problem. The purpose of this work is
to show that Particle Swarm Optimization may provide for more efficient classification as compared to other algorithms. To validate
the approach E.Coli complete genome is taken as the benchmark genome.
Similar to Phenocode Signature Panels Supplier (20)
The EVOM Auto automates measurements of TEER in epithelial or endothelial monolayers cultured on high throughput screening (HTS) 24 and 96-well and plates utilizing our innovative EVOM technology, qualitatively measuring cell monolayer health and quantitatively measuring cell confluence by determining an increase or a plateau in tissue resistance..https://www.gaiascience.com.sg/productdetails/-evom-auto--high-throughput-screening-system-
ELK Biotech offers thousands of enzyme-linked immunosorbent assay (ELISA) kits for researchers, The species include human, mouse, rat, rabbit, monkey, porcine, etc. As a professional ELISA kits manufacturer and supplier, our ELISA test kits have been strictly quality-controlled to ensure the accuracy of results. Elabscience is committed to providing high quality ELISA kits with a very economical price..https://www.gaiascience.com.sg/productdetails/elisa-kit
SOTAX is a leading independent company for pharmaceutical testing equipment. The company owes its independence to its sustained economic success. The SOTAX Group is a global success story and has subsidiaries around the world that are familiar with local needs and practices..https://www.gaiascience.com.sg/branddetails/sotax
Rugged and reliable, the ORIGINAL Vortex-Genie 2 is our most popular vortex mixer. It variable speed control allows high speed shaking or vortexing with tough metal housing. It is ready for use with supplied with 3 inch Platform (shown) and Pop-Off Cup..https://www.gaiascience.com.sg/productdetails/-genie-2--vortex-mixer
IKA ROTAVISC lo-vi HELI Complete determines the viscosity of low-viscosity liquids in all areas of application ranging from the laboratory to quality control. The scope of delivery includes a standard spindle set (SP 1-SP 4), a protective bracket, temperature sensor and HELISTAND stand incl. T-spindle set..https://www.gaiascience.com.sg/productdetails/rotavisc-heli-complete
ELK Biotechnology is a high-tech biological company focusing on the development and production of immune products and molecular biology products. Products cover ELISA kits, antibodies, genome extraction reagents, molecular biology reagents. Involved in immunochemistry, tumor research, neurobiology, cell cycle, signal transduction and other fields..https://www.gaiascience.com.sg/branddetails/elk-biotechnology
Yokogawa is a leading provider of Industrial Automation and Test and Measurement solutions. Combining superior technology with engineering services, project management, and maintenance, Yokogawa delivers field proven operational efficiency, safety, quality, and reliability..https://www.gaiascience.com.sg/branddetails/yokogawa
Dickson has been an industry leader and innovator in environmental monitoring and compliance solutions. From then until now, Dickson’s rich history is marked with innovation in solving the biggest compliance and monitoring challenges in the most heavily regulated industries..https://www.gaiascience.com.sg/branddetails/dickson
HiMedia has ventured into intuitive medicine by means of PCR based detection of anti-microbial markers helping clinicians to decide their drug of choice. They are also enhancing the bioinformatics space for sequencing and post sequencing gene mapping analysis. HiMedia’s insights, ambitions, and accomplishments, in many ways, compliment the stellar community of Indian scientists..https://www.gaiascience.com.sg/branddetails/himedia-laboratories
The FlavourSpec® comprises advantages of a Gas Chromatograph (GC) with regard to selectivity and outstanding sensitivity of an Ion Mobility Spectrometer (IMS) enabling the analysis of volatiles in the headspace of liquids and solid samples without any sample pre-treatment..https://www.gaiascience.com.sg/productdetails/flavourspec
Park FX40 takes care of everything automatically: from tip pick up to landing to full autonomous scanning of the sample at a click of a button. It does this by infusing robotics, AI and machine learning into its groundbreaking FX system..https://www.gaiascience.com.sg/productdetails/park-fx40--atomic-force-microscope
Thermo Scientific Phenom ParticleX Desktop SEM (Scanning Electron Microscope) is a multi-purpose desktop SEM designed for multiple applications at the microscale. The Thermo Scientific Phenom ParticleX is a versatile desktop SEM solution for high quality analysis in-house. It gives you the ability to carry out speedy analysis, verification and classification of materials, supporting, your production with fast, accurate and trusted data..https://www.gaiascience.com.sg/productdetails/phenom-particlex-desktop-sem
Captair Bio 391 Smart Mobile Ductless Filtering PCR WorkstationGaia Science Pte Ltd
Erlab Captair Bio 391 Smart Mobile Ductless Filtering PCR Workstation features a high efficiency filtration system that provides a particulate free atmosphere around the manipulation. A high energy UV light is used to decontaminate the worktop from biological cross-contamination between operations..https://www.gaiascience.com.sg/productdetails/captair-bio-391-smart--mobile-ductless-filtering-pcr-workstation
DLAB Scientific Levo Plus Pipette Filler is an ergonomic fast pipetting solution with accurate speed control. It compatible with most of the plastic and glass pipettes from 0.1 -100mL..https://www.gaiascience.com.sg/productdetails/levo-plus-pipette-filler
Cleaver Scientific are suppliers of a wide range of electrophoresis systems as well as other products and accessories. We manufacture equipment that is used in life science laboratories all over the world. While our core focus is electrophoresis, our extended product range features everything from pipettes to radiation shielding. We offer FREE shipping worldwide on our extensive product range..https://www.gaiascience.com.sg/branddetails/cleaver-scientific
The PhenoCycler™-Fusion allows spatial phenotyping of millions of cells at unprecedented scale and speed. Its Mapping millions of cells and their interactions in a single intact tissue section facilitates the discovery of rare cell types, cellular neighborhoods, and spatial functional states. Push the frontiers of spatial biology with your team using the PhenoCycler solutions (formerly CODEX®)..https://www.gaiascience.com.sg/productdetails/phenocycler--fusion-system
Percival Scientific makes various scientific equipment including the best biological incubators, research chambers, environment control systems etc. Phenospex is a biotech company, which develops and provides hard- and software for automated plant screening and plant phenotyping. JIUPO's main products are environmental controlled rooms, movable plant growth chamber, plant lighting solutions which range from standard style to highly configured style and customized solutions..https://www.gaiascience.com.sg/subcategories/plant-biology
Cleaver Scientific manufacture equipment that is used in life science laboratories all over the world. While our core focus is electrophoresis, our extended product range features everything from pipettes to radiation shielding..https://www.gaiascience.com.sg/branddetails/cleaver-scientific
Gaia Science supplying a wide range of scientific and laboratory equipment to universities, research institutions, and industries. We have large essentials like freezers, ovens, or an incubator, microscopes, refractometers, and water baths, spatulas, and pH meters and etc..https://www.gaiascience.com.sg/
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
1. Recently Akoya announced the launch of PhenoCode™ Signature Panels for high-throughput spatial
biomarker discovery and validation on the PhenoImager® platforms, providing the flexibility to keep
pace with the dynamic combination therapy landscape.
Additionally, Akoya has brought new datasets of spatial imaging of complementary RNA and protein
biomarkers on the PhenoCycler®-Fusion system, which reveal insights into tumor biology and
immunotherapy response.
Rapid whole-slide spatial analysis of FFPE tissues
with true multiomic panels enables the discovery of
key cellular niches
These multiomic data show the value of using protein
imaging data for cell typing and clearer differentiation
and overlaying RNA imaging data to understand the
functional state of those same cells of interest.
RNA chemistry is combined with protein chemistry on
the PhenoCycler-Fusion (PCF) imaging system, users
can obtain more exquisite cell typing while
understanding specific functional states of each cell.
Multiomic Spatial Phenotyping of Immunotherapy
Responses in Head and Neck Cancer
This poster demonstrates how multiomic spatial
phenotyping was used to produce a uniquely
comprehensive analysis of the patient's tumor
microenvironment (TME) and how it explains partial
response to immune checkpoint inhibitor therapy.
Compared to traditional H&E staining, using the
powerful multiomic (RNA + protein) assay on the
same tissue of serial sections, researchers can see the
dynamic interplay of cells and their functional states
in the heterogeneous TME.
New Product Introduction
Empower Your
Spatial Multiomics
Research
Posters: Spatial Imaging of Complementary RNA and Protein Biomarkers
PhenoCode Signature panels blend the sensitivity of the Opal-
TSA detection system with features of Akoya's proprietary
barcode-based antibody labeling chemistry on the PhenoImager
platforms. It allows for the easy integration of a novel checkpoint
or immune cell marker; these panels offer 3-fold faster assay
development and optimization times compared to other custom
6-plex panels.
Jumpstart Spatial Signatures
View more posters and recordings of the talks at AGBT 2023
View more posters and recordings of the talks at AGBT 2023